Safety and tolerability profile of daclizumab in patients with relapsing-remitting multiple sclerosis: An integrated analysis of clinical studies.

Giovannoni G, Kappos L, Gold R, Khatri BO, Selmaj K, Umans K, Greenberg SJ, Sweetser M, Elkins J, McCroskery P

Mult Scler Relat Disord. 2016 Sep; 9:36-46. Epub 2016 May 11. PMID: 27645341. Abstract